Prosonix appoints chief medical officer
Oxford firm hires respiratory drug development expert Dr Geoff Down
Down has more than 18 years’ clinical development experience in the pharmaceutical sector, following 10 years in clinical practice.
He joins Prosonix after running his own company, providing services as a consultant pharmaceutical physician. During this period he worked in clinical safety for Pfizer r&d, in clinical development for RespiVert Ltd (a spinout from Imperial Innovations that aims to identify new treatments for COPD, cystic fibrosis and severe asthma), and since December 2010 he has been working in clinical pharmacology at GlaxoSmithKline’s r&d Respiratory and Immuno-Inflammation medicines development centre (GSK RII MDC).
Dr Down has been a principal investigator or company sponsor for more than 50 early clinical development studies, including first-in-human studies, and in excess of 30 full clinical development trials.
